Literature DB >> 27527698

The Role of Additional Sex Combs-Like Proteins in Cancer.

Jean-Baptiste Micol1, Omar Abdel-Wahab2.   

Abstract

Additional sex combs-like (ASXL) proteins are mammalian homologs of Addition of sex combs (Asx), a protein that regulates the balance of trithorax and Polycomb function in Drosophila. All three ASXL family members (ASXL1, ASXL2, and ASXL3) are affected by somatic or de novo germline mutations in cancer or rare developmental syndromes, respectively. Although Asx is characterized as a catalytic partner for the deubiquitinase Calypso (or BAP1), there are domains of ASXL proteins that are distinct from Asx and the roles and redundancies of ASXL members are not yet well understood. Moreover, it is not yet fully clarified if commonly encountered ASXL1 mutations result in a loss of protein or stable expression of a truncated protein with dominant-negative or gain-of-function properties. This review summarizes our current knowledge of the biological and functional roles of ASXL members in development, cancer, and transcription.
Copyright © 2016 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27527698      PMCID: PMC5046687          DOI: 10.1101/cshperspect.a026526

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  78 in total

1.  De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome.

Authors:  Alexander Hoischen; Bregje W M van Bon; Benjamín Rodríguez-Santiago; Christian Gilissen; Lisenka E L M Vissers; Petra de Vries; Irene Janssen; Bart van Lier; Rob Hastings; Sarah F Smithson; Ruth Newbury-Ecob; Susanne Kjaergaard; Judith Goodship; Ruth McGowan; Deborah Bartholdi; Anita Rauch; Maarit Peippo; Jan M Cobben; Dagmar Wieczorek; Gabriele Gillessen-Kaesbach; Joris A Veltman; Han G Brunner; Bert B B A de Vries
Journal:  Nat Genet       Date:  2011-06-26       Impact factor: 38.330

2.  BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.

Authors:  D E Jensen; M Proctor; S T Marquis; H P Gardner; S I Ha; L A Chodosh; A M Ishov; N Tommerup; H Vissing; Y Sekido; J Minna; A Borodovsky; D C Schultz; K D Wilkinson; G G Maul; N Barlev; S L Berger; G C Prendergast; F J Rauscher
Journal:  Oncogene       Date:  1998-03-05       Impact factor: 9.867

3.  ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.

Authors:  Michelle A Elliott; Animesh Pardanani; Curtis A Hanson; Terra L Lasho; Christy M Finke; Alem A Belachew; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2015-07       Impact factor: 10.047

4.  The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.

Authors:  Matthew Bott; Marie Brevet; Barry S Taylor; Shigeki Shimizu; Tatsuo Ito; Lu Wang; Jenette Creaney; Richard A Lake; Maureen F Zakowski; Boris Reva; Chris Sander; Robert Delsite; Simon Powell; Qin Zhou; Ronglai Shen; Adam Olshen; Valerie Rusch; Marc Ladanyi
Journal:  Nat Genet       Date:  2011-06-05       Impact factor: 38.330

5.  Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes.

Authors:  Brady L Stein; Donna M Williams; Christine O'Keefe; Ophelia Rogers; Roxann G Ingersoll; Jerry L Spivak; Amit Verma; Jarek P Maciejewski; Michael A McDevitt; Alison R Moliterno
Journal:  Haematologica       Date:  2011-06-28       Impact factor: 9.941

6.  Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.

Authors:  Véronique Gelsi-Boyer; Virginie Trouplin; José Adélaïde; Julien Bonansea; Nathalie Cervera; Nadine Carbuccia; Arnaud Lagarde; Thomas Prebet; Meyer Nezri; Danielle Sainty; Sylviane Olschwang; Luc Xerri; Max Chaffanet; Marie-Joëlle Mozziconacci; Norbert Vey; Daniel Birnbaum
Journal:  Br J Haematol       Date:  2009-04-15       Impact factor: 6.998

7.  The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.

Authors:  Salima Daou; Ian Hammond-Martel; Nazar Mashtalir; Haithem Barbour; Jessica Gagnon; Nicholas V G Iannantuono; Nadine Sen Nkwe; Alena Motorina; Helen Pak; Helen Yu; Hugo Wurtele; Eric Milot; Frédérick A Mallette; Michele Carbone; El Bachir Affar
Journal:  J Biol Chem       Date:  2015-09-28       Impact factor: 5.157

8.  ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.

Authors:  U-H Park; M-R Kang; E-J Kim; Y-S Kwon; W Hur; S K Yoon; B-J Song; J H Park; J-T Hwang; J-C Jeong; S-J Um
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

9.  The Additional sex combs gene of Drosophila encodes a chromatin protein that binds to shared and unique Polycomb group sites on polytene chromosomes.

Authors:  D A Sinclair; T A Milne; J W Hodgson; J Shellard; C A Salinas; M Kyba; F Randazzo; H W Brock
Journal:  Development       Date:  1998-04       Impact factor: 6.868

10.  Functional conservation of Asxl2, a murine homolog for the Drosophila enhancer of trithorax and polycomb group gene Asx.

Authors:  Heather A Baskind; Lucy Na; Quanhong Ma; Mayur P Patel; David L Geenen; Q Tian Wang
Journal:  PLoS One       Date:  2009-03-09       Impact factor: 3.240

View more
  19 in total

Review 1.  Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms.

Authors:  Shuhei Asada; Toshio Kitamura
Journal:  Int J Hematol       Date:  2018-12-05       Impact factor: 2.490

2.  ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.

Authors:  Vivek Shukla; Mahadev Rao; Hongen Zhang; Jeanette Beers; Darawalee Wangsa; Danny Wangsa; Floryne O Buishand; Yonghong Wang; Zhiya Yu; Holly S Stevenson; Emily S Reardon; Kaitlin C McLoughlin; Andrew S Kaufman; Eden C Payabyab; Julie A Hong; Mary Zhang; Sean Davis; Daniel Edelman; Guokai Chen; Markku M Miettinen; Nicholas P Restifo; Thomas Ried; Paul A Meltzer; David S Schrump
Journal:  Cancer Res       Date:  2017-09-21       Impact factor: 12.701

Review 3.  Clonal Hematopoiesis and Its Impact on Cardiovascular Disease.

Authors:  Soichi Sano; Ying Wang; Kenneth Walsh
Journal:  Circ J       Date:  2018-09-04       Impact factor: 2.993

4.  Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network.

Authors:  Yu-Kun Xia; Yi-Rong Zeng; Meng-Li Zhang; Peng Liu; Fang Liu; Hao Zhang; Chen-Xi He; Yi-Ping Sun; Jin-Ye Zhang; Cheng Zhang; Lei Song; Chen Ding; Yu-Jie Tang; Zhen Yang; Chen Yang; Pu Wang; Kun-Liang Guan; Yue Xiong; Dan Ye
Journal:  Protein Cell       Date:  2020-07-18       Impact factor: 14.870

Review 5.  Roles and mechanisms of BAP1 deubiquitinase in tumor suppression.

Authors:  Louis Masclef; Oumaima Ahmed; Benjamin Estavoyer; Bruno Larrivée; Nathalie Labrecque; Anastasia Nijnik; El Bachir Affar
Journal:  Cell Death Differ       Date:  2021-01-18       Impact factor: 12.067

Review 6.  Identification of differential microRNAs and messenger RNAs resulting from ASXL transcriptional regulator 3 knockdown during during heart development.

Authors:  Ze-Qun Liu; Mi Cheng; Fang Fu; Ru Li; Jin Han; Xin Yang; Qiong Deng; Lu-Shan Li; Ting-Ying Lei; Dong-Zhi Li; Can Liao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

7.  Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer.

Authors:  Huimei Yu; Yuanyuan Jiang; Lanxin Liu; Wenqi Shan; Xiaofang Chu; Zhe Yang; Zeng-Quan Yang
Journal:  Oncotarget       Date:  2017-02-21

8.  Hyperventilation-athetosis in ASXL3 deficiency (Bainbridge-Ropers) syndrome.

Authors:  Rubina Dad; Susan Walker; Stephen W Scherer; Muhammad Jawad Hassan; Suk Yun Kang; Berge A Minassian
Journal:  Neurol Genet       Date:  2017-09-22

9.  ASXL1 mutations in Chinese patients with essential thrombocythemia.

Authors:  Yan-Bo Nie; Meng Sun; Colin K He; Man-Kai Ju; Fu-Ling Zhou; San-Yun Wu; Yi Zhou; Li Liu; Hui Shen; Ting-Ting Huang; Pan Liu; Ying Xu; Liang Shao; Xue-Lan Zuo
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

10.  Bainbridge-ropers syndrome caused by loss-of-function variants in ASXL3: Clinical abnormalities, medical imaging features, and gene variation in infancy of case report.

Authors:  Linfeng Yang; Bin Guo; Weiwei Zhu; Lei Wang; Bingjuan Han; Yena Che; Lingfei Guo
Journal:  BMC Pediatr       Date:  2020-06-09       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.